Cephalalgia - Volume 17, Number 17

June 1997

Select all

Introduction
Restricted accessIntroductionFirst published June, 1997pp. 1-1
Introduction
Research article
Restricted accessResearch articleFirst published June, 1997pp. 2-5
From genetics to prophylaxis
Michel Ferrari
Research article
Restricted accessResearch articleFirst published June, 1997pp. 6-9
How to define the best efficacy parameters for migraine
Peer Tfelt-Hansen
Research article
Restricted accessResearch articleFirst published June, 1997pp. 10-11
Is a central action of acute antimigraine drugs essential?
Peter J. Goadsby
Research article
Restricted accessResearch articleFirst published June, 1997pp. 12-16
Measuring central action of acute antimigraine drugs in humans
Jean Schoenen
Research article
Restricted accessResearch articleFirst published June, 1997pp. 17-20
Would any acute treatment for migraine demonstrate recurrence?
Carl Dahlöf
Research article
Restricted accessResearch articleFirst published June, 1997pp. 21-24
What is lacking in the treatment of paediatric and adolescent migraine?
Hélène Massiou
Research article
Restricted accessResearch articleFirst published June, 1997pp. 25-28
What is the role of international societies and what could they do better?
Fabio Antonaci